HUNTINGTON BEACH, Calif. — A growing body of data suggest GLP-1 receptor agonists may demonstrate direct anti-inflammatory properties beyond weight loss, according to data presented at the Congress of Clinical Rheumatology West.
In his presentation, Leonard H. Calabrese, DO, RJ Fasenmyer chair of clinical immunology in the department of rheumatic and immunologic diseases at Cleveland Clinic, told attendees that the latest data additionally point to the possibility that these effects are mediated by the brain-immune axis.
“There is a lot of excitement about the use of GLP-1s and

A JAMA Network Open analysis of more than 2 million autistic Medicaid enrollees found a life expectancy of 64.9 years, with preventable causes leading.

Florida added 41 locally acquired dengue cases in one week, with 134 in Hillsborough County. What Tampa Bay residents should know now.

FDA cleared Amneal's generic lanreotide, and it launched immediately. Why more competition has not yet cut what patients pay for monthly injections.

A University of Chicago analysis of 11 years of federal survey data found that GLP-1 use in diabetes patients did not shift mental health or employment.

CDC rebuilt its state respiratory activity scale for 2026–27, but Iowa, Missouri, and South Dakota carry data gaps as the fall illness season opens.

CDC data show 363 of 504 West Nile cases in 2026 are neuroinvasive, even as totals run below 2025. What older adults should do now.

Minnesota confirms H5N1 at three more poultry operations as wild waterfowl detections rise. Who faces real risk this fall, and what to do.

Old age and forgetfulness seem to go hand in hand. But my colleagues and I found that memories actually become less precise, not entirely forgotten. Our study, published in the journal Cerebral Cortex, shows how the brain blends related experiences as you age rather than replaying the exact one you need.

Emergency contraception containing mifepristone prevents more pregnancies with fewer side effects than some other common emergency contraceptive pills, such as levonorgestrel, according to a new review involving 87 trials.